How much funding has RaeSedo, LLC raised?

RaeSedo, LLC has raised $3.4M in total funding, most recently a Grant round.

Who are RaeSedo, LLC's investors?

RaeSedo, LLC's investors include National Institutes of Health.

When was RaeSedo, LLC founded?

RaeSedo, LLC was founded in 2020.

Where is RaeSedo, LLC headquartered?

RaeSedo, LLC is headquartered in Tucson, Arizona, United States.

What industry is RaeSedo, LLC in?

RaeSedo, LLC operates in Biotech, Healthcare.

How many employees does RaeSedo, LLC have?

RaeSedo, LLC has 1-10 employees.

RaeSedo, LLC

A revolutionary class of asthma therapeutics

Tucson, United States · Founded 2020 · $3.4M raised

Biotech

Healthcare

Headquarters: Tucson, Arizona
Employees: 1–10
Founded: 2020
Business Model: B2G

Website: raesedoinc.com
Total Funding: $3.4M
Last Round: $3.4M GrantNov 2022
Rounds: 1

About

RaeSedo is a clinical-stage biopharmaceutical company developing a novel inhaled peptide therapeutic for asthma derived from surfactant protein-A (SP-A), a naturally occurring lung protein with innate immune properties. The company's lead candidate targets airway inflammation, mucus production, and bronchoconstriction across all asthma types. Founded by University of Arizona physician-scientists with over a decade of continuous NIH funding.

Summary

RaeSedo, LLC is a Biotech company based in Tucson, United States, founded in 2020. It has raised $3.4M in total across 1 round, most recently a $3.4M Grant round in Nov 2022. Investors include National Institutes of Health.